Regenerative Therapy represents an innovative approach in medicine aimed at harnessing the body's natural healing abilities to repair and replace damaged tissues. This emerging field encompasses various strategies, including stem cell therapy, tissue engineering, and growth factor administration. Stem cells, with their unique ability to differentiate into different cell types, hold tremendous potential in regenerative medicine. These cells can be sourced from various places, such as bone marrow, adipose tissue, or embryonic tissues. Tissue engineering involves creating artificial organs or tissues in the laboratory, often using a combination of cells, biomaterials, and growth factors. Growth factors, signaling molecules that stimulate cellular activities, play a crucial role in promoting tissue repair and regeneration. Regenerative therapies are being explored for a wide range of medical conditions, including cardiovascular diseases, neurodegenerative disorders, and musculoskeletal injuries. While the field is still in its early stages, the potential to revolutionize treatment approaches, particularly for conditions with limited therapeutic options, is substantial. Ongoing research aims to refine techniques, address safety concerns, and broaden the scope of regenerative therapy applications, paving the way for a new era in personalized and regenerative medicine.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy